Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16.1M
+27.5% from 2023
Prescriptions
3,060
$5,255.29 per claim
Patients
540
261 prescribers
Total spending, 2024
$16.1M
$29,780.00 per patient
Medicare prescription drug plans paid $16.1M for Mvasi in 2024, for 3,060 prescriptions and refills to 540 patients (up 27.5% from 2023). The average cost per claim was $5,255.29.
New York had the highest Medicare cost for Mvasi in 2024: $4.0M for 665 claims, followed by Arkansas ($3.1M).
Kamal Patel, hematology-oncology in Little Rock, AR, had the highest Medicare cost for Mvasi in 2024: 139 claims costing $828K.
Mvasi is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kamal Patel Little Rock, AR | Hematology-Oncology | 139 | 16 | $828K |
| Omer Khalil Little Rock, AR | Hematology-Oncology | 95 | 11 | $472K |
| Ashvini Sengar Gadsden, AL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 172 | 1,594 | 325 | $10.0M |
| 2023 | 183 | 2,033 | 386 | $12.6M |
| 2024 | 261 | 3,060 | 540 | $16.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 68 |
| 15 |
| $455K |
| Deepali Sharma Riverhead, NY | Internal Medicine | 35 | Under 11 | $309K |
| Shahab A Khan Houston, TX | Hematology-Oncology | 69 | Under 11 | $295K |
| Santosh M Nair Orange City, FL | Hematology-Oncology | 44 | Under 11 | $268K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 49 | 11 | $260K |
| Balagopalan Nair Little Rock, AR | Hematology-Oncology | 88 | 11 | $253K |
| Waqas Rehman Flemington, NJ | Hematology-Oncology | 37 | Under 11 | $242K |
| Yasir Alhassani Temple Terrace, FL | Hematology-Oncology | 46 | Under 11 | $231K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 49 | Under 11 | $230K |
| Jamie Burton Little Rock, AR | Hematology | 27 | Under 11 | $194K |
| Satish A Shah Gettysburg, PA | Hematology-Oncology | 38 | Under 11 | $192K |
| Sanjeev Jain East Patchogue, NY | Hematology-Oncology | 20 | Under 11 | $191K |
| Regina L Jablonski Port Jefferson Station, NY | Hematology-Oncology | 37 | Under 11 | $188K |
| George Cyriac Port Jefferson Station, NY | Hematology-Oncology | 27 | Under 11 | $183K |
| Eugenio G Galindo McAllen, TX | Hematology-Oncology | 26 | Under 11 | $182K |
| Derek Middleton Little Rock, AR | Hematology-Oncology | 52 | Under 11 | $173K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 50 | Under 11 | $169K |
| Jacob Tangir Miramar, FL | Gynecological Oncology | 25 | Under 11 | $167K |
| David A Richards Somerset, NJ | Hematology-Oncology | 33 | Under 11 | $164K |
| Andrew Briggler Little Rock, AR | Hematology-Oncology | 30 | Under 11 | $163K |
| Byung M Kim Elmhurst, NY | Medical Oncology | 25 | Under 11 | $163K |
| Roy H Chen Riverhead, NY | Hematology-Oncology | 22 | Under 11 | $161K |
| Amory V Novoselac New York, NY | Hematology-Oncology | 37 | Under 11 | $159K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Amgen AMGN | 3,060 | $16.1M |